Taiwan FDA registration cbefd5f6f0017ee3f0614d467bd27820
Microferoc 2 gram-positive bacterium drug Minka antibiotic-cefalolin
TW: 微鐵克2革蘭氏陽性菌藥敏卡抗生素-頭孢洛林
Taiwan·Risk Class 2·bioMérieux, Inc.·Registered Mar 17, 2020 – Mar 17, 2030ActiveRegistration details
- Analysis ID
- cbefd5f6f0017ee3f0614d467bd27820
- Customs Code
- DHA05603329202
Company information
- Manufacturer
- bioMérieux, Inc.
- Manufacturer Country
- United States
- Authorized Representative
- BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG)
Product details
- Intended Use
- This product can be used with Microtek 2 automatic microbial analyzer to measure the antibiotic susceptibility of staphylococcus, enterococcus and Streptococcus agalactis in vitro in clinical laboratories.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1640 抗菌感受性試驗粉末
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Mar 17, 2020
- Expiry Date
- Mar 17, 2030
About this record
Access comprehensive regulatory information for Microferoc 2 gram-positive bacterium drug Minka antibiotic-cefalolin in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cbefd5f6f0017ee3f0614d467bd27820 and manufactured by bioMérieux, Inc.. The authorized representative in Taiwan is BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices